Natural resins and bioactive natural products thereof as potential anitimicrobial agents

Current Pharmaceutical Design

Volumn 17, Issue 13, 2011, Pages 1267-1290

  Termentzi, Aikaterini ^a   Fokialakis, Nikolas ^a   Skaltsounis, Alexios Leandros ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Antibacterial; Antifungal antiprotozoal activity; Antimicrobial; Gums; Natural products; Oleoresins; Resins

Indexed keywords

3 CARENE; 7 OXO DEHYDROABIETIC ACID; ABIETA 7,13 DIENE; ABIETA 8,11,13 TRIENE; ABIETIC ACID; ANTIINFECTIVE AGENT; BETA PHELLANDRENE; DEHYDROABIETIC ACID; DITERPENE; ESSENTIAL OIL; ISOPIMARIC ACID; LIMONENE; LONGIFOLENE; MANOOL; MOLECULAR SCAFFOLD; NATURAL PRODUCT; OXO DEISOPROPYLDEHYDROABIETATE; PARA CYMENE; PIMARIC ACID; PINENE; PLANT EXTRACT; RESIN; ROSIN; SESQUITERPENE; TERPENE; TERPINEN 4 OL; TERPINEOL; TERPINOLENE; TURPENTINE OIL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ABIES; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ANTIPROTOZOAL ACTIVITY; BOSWELLIA; BURN; BURSERACEAE; CEDRUS; CHAMAECYPARIS; COMMIPHORA; CROTON; CYTOTOXICITY; DRACAENA; DRUG ACTIVITY; DRUG SYNTHESIS; FENNEL; INFLAMMATION; NONHUMAN; PINACEAE; PISTACIA LENTISCUS; PRIORITY JOURNAL; REVIEW; SKIN DISEASE; STRUCTURE ACTIVITY RELATION; WOUND;

EID: 79958120627     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161211795703807     Document Type: Review

References (174)

1. Easterlin RA. The worldwide standard of living since 1800. J Econ Perspect 2000; 14: 7-26.
2. Gold HS, Moellering Jr. RC. Antimicrobial-drug resistance. New Eng J Med 1996; 335: 1445-53.
3. Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod 2007; 70: 461-77.
4. Newman DJ. Natural products as leads to potential drugs: An old process or the new hope for drug discovery? J Med Chem 2008; 51: 2589-99.
5. Lam KS. New aspects of natural products in drug discovery. TIM 2007; 15: 279-89.
6. Saleem M, Nazir M, Shaiq Ali M, et al. Antimicrobial natural products: an update on future antibiotic drug candidates. Nat Prod Rep 2010; 27: 238-54.
7. Shahid M, Shahzad A, Sobia F, et al. Umesh Plant natural products as a potential source for antibacterial agents: Recent trends 2009 Anti-Infect Ag Med Chem 8 (3), pp. 211-25.
8. Cowan MM. Plant Products as Antimicrobial Agents. Clin Microbiol Rev 1999; 12: 564-82.
9. Rios JL, Recio MC, Villar A. Screening methods for natural products with antimicrobial activity: A review of the literature. J Ethnopharmacol 1988; 23: 127-49.
10. Das K, Tiwari RKS, Shrivastava DK, Techniques for evaluation of medicinal plant products as antimicrobial agent: Current methods and future trends. J Med Plants Res 2010; 4: 104-11.
11. Croteau R, Johnson MA. In: Higuichi T, Ed. Biosynthesis and biodegradation of wood components. Biosynthesis of terpenoid wood extractives 1985; pp 379-439.
12. Mutton DB. Wood resin. In: Hillispp WE, Ed. Wood extractives. New York: Academic 1962; pp 331-63.
13. Norin T. Some aspects of the chemistry of the order pinales. Phytochem 1972; 11: 1231-42.
14. Gijzen M, Lewinsohn E, Savage TJ, Croteau RB. In: Teranishi R, Buttery RG, Sugisawa H, Eds. Bioactive volatile compounds from plants. Conifer monoterpenes: biochemistry and bark beetle chemical ecology. Washington DC: Am Chemical Society 1993; pp 822.
15. Hu XM, Zhang WK, Song LR, et al. Chinesse Materia Medica, Shanghai Science and Technology Press, Shanghai 1998; 2: 303-5.
16. San Feliciano A, Gordaliza M, Salinero M, Del Corral MJ. Abietane acids: sources, biological activities, and therapeutic uses. Planta Med 1993; 5: 485-90.
17. Simbirtsev AS, Konusova VG, Mchelidze GS, Fidarov EZ, Paramonov BA, Chebotarev VY. Pine resin and biopin ointment: Effects on repair processes in tissues. Bull Exp Biol Med+ 2002; 113: 457-60.
18. Kersten PJ, Kopper BJ, Raffa KF, Illman BL. Rapid Analysis of abietanes in conifers. J Chem Ecol 2006; 32: 2679-85.
19. Carman RM, Marty RA. Diterpenoids. XXIV. Agathis species of North Queensland. Two new resin acids. Aust J Chem 1970; 23: 1457-64.
20. Himejima M, Hobson KR, Otsuka T, Wood DL, Kubo I. Antimicrobial terpenes from oleoresin of Ponderosa pine tree Pinus ponderosa: A defence mechanism against microbial invasion. J Chem Ecol 1992; 18: 10.
21. Savluchinske-Feio S, João Marcelo Curto M, Gigante B, Carlos Roseiro J. Antimicrobial activity of resin acid derivatives. Appl Microbiol Biotechnol 2006; 72: 430-6.
22. Soderberg TA, Holm S, Gref R, Hallmans G. Antibacterial effects of zinc oxide, rosin and resin acids with special reference to their interactions. Scand J Plast Recons 1991; 25: 19-24.
23. Vargas I, Sanz I, Moya P, Prima-Yufera E. Antimicrobial and antioxidant compounds in the nonvolatile fraction of expressed orange essential oil. J Food Protect 1999; 62: 929-32.
24. Kopper BJ, Illman BL, Kersten PJ, Klepzig KD, Raffa KF. Effects of diterpene acids on components of a conifer bark beetle-fungal interaction. Environ Entomol 2005; 34: 486-93.
25. Smith E, Williamson E, Zloh M, Gibbons S. Isopimaric acid from Pinus nigra shows activity against multidrug-resistant and EMRSA strains of Staphylococcus aureus. Phytother Res 2005; 19: 538-42.
26. Franich RA, Gadgil PD, Sham L. Fungistatic effects of Pinus radiata needle epicuticular fatty and resin acids on Dothistroma pini. Physiol Plant Pathol 1983; 23: 183-95.
27. Henricks LM, Ekman R, von Weissenberg K. Bioassay of some resin and fatty acids with Fomes annosus. Acta Academiae Aboensis Serb 1979; 39: 1-7.
28. Clemente A, Karmali A, Gigante B, et al. A direct bioautographic assay for resin acid derivatives with fungistatic activity. Cienc Biol 1987; 12: 261.
29. Muftic M. Dehydroabietylguanidin (DAG) ein Breitspektriges Semisynthetisches Antibiotikum mit Besonderer Wirkung Gegen Mykobakterium. Z F Tuberk 1968; 129: 305-10.
30. Muftic M. Essay on antibiotic properties of abietyl compounds. Q J Crude Drug Res 1970; 10: 1601-7.
31. Schröder F, Albrecht R, Rufer C. Dihydroabietylamin Derivatives und ihre Antibakterielllen Figenoschagten. Arzneim-Forsch 1970; 20: 737-43.
32. Fukui H, Koshimizu K, Egawa H. A new diterpene with antimicrobial activity from Chamaecyparis pisifera Endle. Agric Biol Chem 1978; 42: 1419-23.
33. Gigante B, Silva AM, Marcelo Curto MJ, Savluchinske Feio S, Roseiro JC, Reis VR. Structural effects on the bioactivity of dehydroabietic acid derivatives. Planta Med 2002; 68: 680-4.
34. Savluchinske-Feio S, Gigante B, Carlos Roseiro J, Marcelo-Curto MJ. Antimicrobial activity of diterpene resin acid derivatives. J Microbiol Meth 1999; 35: 201-6.
35. Savluchinske-Feio S, Carlos Roseiro J, Gigante B, Marcelo-Curto MJ. Method on multiwall plates for the evaluation of the antimicrobial activity of resin acid derivatives. J Microbiol Meth 1997; 28: 201-6.
36. Savluchinske-Feio S, Franca S, Silva AM, Gigante B, Roseiro JC, Marcelo Curto MJ. Antimicrobial activity of methyl cis-7-oxo deisopropyldehydroabietate on Botrytis cinerea and Lophodermium seditiosum. Morphological studies by TEM. J Appl Microbiol 2002; 93:765-71.
37. Soderberg TA, Johanssonb A, Grefc R. Toxic effects of some conifer resin acids and tea tree oil on human epithelial and fibroblast cells. Toxicology 1996; 107: 99-109.
38. Hausen BM, Krueger A, Mohnert J, Hahn H, Konig WA. Contact allergy due to colophon (III). Sensitizing potency of resin acids and some related products. Contact Dermatitis, 1989; 20: 41-50.
39. Lee JH, Lee BK, Kim JH, Lee SH, Hong SK. Comparison of chemical compositions and antimicrobial activities of Essential oils from three conifer trees: Pinus densiflora, Cryptomeria japonica, and Chamaecyparis obtuse. J Microbiol Biotechn 2009; 19: 391-6.
40. Stojković D, Soković M, Glamočlija J, et al. Susceptibility of three clinical isolates of Actinomodura madurae to α-pinene, the bioactive agent of Pinus pinaster turpentine oil. Arch Biol Sci 2008; 60: 697-701.
41. Opdyke DLJ. α-pinene. Food Cosmet Toxicol 1978; 16: 853-7.
42. 3-carene. Food Cosmet Toxicol 1973; 11: 1053.
43. Opdyke DLJ. Terpinolene. Food Cosmet Toxicol 1976; 14: 877.
44. Diǧrak M, Ilcim A, Hakki{dotless} Alma M. Antimicrobial Activities of Several Parts of Pinus brutia, Juniperus oxycedrus, Abies cilicia, Cedrus libani and Pinus nigra. Phytother Res 1999; 13: 584-7.
45. Kizil M, Kizil G, Yavuz M, Aytekin C. Antimicrobial Activity of Resins Obtained from the Roots and Stems of Cedrus libani and Abies Cilicia. Appl Biochem Microbiol 2002; 38: 144-6.
46. Necmettin Y, Alma MH, Nitz S, Kollmannsberger H, Efe FT. Chemical composition of the essential oils from oleoresin on cones of Cedrus libani. Asian J Chem 2005; 17: 2300-6.
47. Tumen I, Hafizoglu H, Kilic A, Dönmez IE, Sivrikaya H, Reunanen M. Yields and Constituents of Essential Oil from Cones of Pinaceae spp. Natively Grown in Turkey. Molecules 2010; 15: 5797-806.
48. Larionova TV, Minina SA, Elinov NP. Optimization of the extraction process and investigation of the antimicrobial action of the oleoresin of the Siberian fir. Pharm Chem J 1976; 10: 102-6.
49. Baytop A. Treatment with Medicinal Plants in Turkey, 2nd Ed. Nobel Tip Kitapevleri, Istanbul, Turkey 1999.
50. Dayisoylu SK, Duman AD, Hakki Alma M, Digrak M. Antimicrobial activity of the essential oils of rosin from cones of Abies cilicica subsp. cilicica. Afr J Biotechn 2009; 8: 5021-24.
51. Kobayashi K, Nishino C, Tomita H, Fukushima H. Antifungal activity of pisiferic acid derivatives against the rice blast fungus. Phytochem 1987; 26: 3175-9.
52. Akatsuka T, Kodama O, Sekido H, Kono Y, Takeuchi S. Novel phytoalexins (Oryzalexins A, B and C) isolated from rice blast infected with Pyricularia oryzae. Part I: Isolation, characterization and biological activities of oryzalexins. Agric Biol Chem 1985; 49: 1689-94.
53. Vaziri A. Antimicrobial action of Galbanum. Planta Med 1975; 28: 370-3.
54. Ghannadi A, Amree S. Volatile oil constituents of Ferula gummosa Boiss. from Kashan, Iran. JEOR 2002; 14: 420-1.
55. Mortazaienezhad F, Sadeghian MM. Investigation of compounds from galbanum (Ferula gummosa) boiss. Asian J Plant Sci 2006; 5: 905-6.
56. Eftekhar F, Yousefzadi M, Borhani K. Antibacterial activity of the essential oil from Ferula gummosa seed. Fitoterapia 2004; 75: 758-9.
57. Ghasemi Y, Faridi P, Mehregan I, Mohagheghzadeh A. Ferula gummosa fruits: An aromatic antimicrobial agent. Chem Nat Comp 2005; 41: 311-4.
58. Moussaieff A, Mechoulam R. Boswellia resins: From religious ceremonies to medical uses: a review of in vitro, in-vivo and clinical trials. J Pharm Pharmacol 2009; 61: 1-13.
59. Shen T, Lou HX. Bioactive constituents of myhrr and frankincense, two simultaneously prescribed gum resins in Chinese traditional medicine. Chem Biodivers 2008; 5: 540-53.
60. Poeckel D, Wertz O. Boswellic acids: biological actions and molecular targets. Curr Med Chem 2006; 13: 3359-69.
61. Moussaieff A, Shohami E, Kashman Y, et al. Incensole acetate, a novel anti-inflammatory compound isolated from Boswellia resin, inhibits nuclear factorkappa B activation. Mol Pharmacol 2007; 72: 1657-64.
62. Roy S, Khanna S, Shah H, et al. Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cells. DNA Cell Biol 2005; 24: 244-55.
63. Ammom H.P. Boswellic acids in chronic inflammatory diseases. Planta Med 2006; 12: 1100-16.
64. Singh S, Khajuria A, Taneja SC, Khajuria RK, Singh J, Qazi GN. Boswellic acids and glucosamine show synergistic effect in preclinical anti-inflammatory study in rats. Bioorg Med Chem Lett 2007; 17: 3706-11.
65. Reddy GK, Chandrakasan G, Dhar SC. Studies on the metabolism of glycosaminoglycans under the influence of new herbal antiinflammatory agents. Biochem Pharmacol 1989; 38: 3527-34.
66. Hamm S, Bleton J, Connan J, Tchapla A. A chemical investigation by headspace SPME and GC-MS of volatile and semi-volatile terpenes in various olibanum samples. Phytochem 2005; 66: 1499-514.
67. Van Vuuren SF, Kamatou GPP, Viljoen AM. Volatile composition and antimicrobial activity of twenty commercial frankincense essential oil samples. S Afr J Bot 2010; 76: 686-91.
68. Mikhaeil BR, Maatooq GT, Badria FA, Amer MM. Chemistry and immunomodulatory activity of frankincense oil. Z Naturforsch C 2003; 58: 230-8.
69. Camarda L, Dayton T, Di Stefano V, Pitonzo R, Schillaci D. Chemical composition and antimicrobial activity of some oleogum resin essential oils from Boswellia spp. (Burseraceae). Ann Chim 2007; 97: 837-44.
70. Schillaci D, Arizza V, Dayton T, Camarda L, Di Stefano V. In vitro anti-biofilm activity of Boswellia spp. oleogum resin essential oils. Lett Appl Microbiol 2008; 47: 433-8.
71. Abdallah EM, Khalid AS, Ibrahim N. Antibacterial activity of oleogum resins of Commiphora molmol and Boswellia papyrifera against methicillin resistant Staphylococcus aureus (MRSA). Sci Res Essays 2009; 4: 351-6.
72. Karaman I, Sahin F, Güllüce M, Ögütcü H, Sengül M, Adigüzel A. Antimicrobial activity of aqueous and methanol extracts of Juniperus oxycedrus L. J Ethnopharmacol 2003; 85: 231-5.
73. Van Wyk BE, Wink M. Medicinal plants of the world an illustrated scientific guide to important medicinal plants and their uses. Portland, Oregon: Timber Press 2010.
74. Saeed AM, Sabir AW. Antibacterial activities of some constituents from oleo-gum-resin of Commiphora mukul. Fitoterapia 2004; 75: 204-8.
75. Claeson P, Samuelsson G. Screening of some Somalian medicinal plants for antidiarrhoeal effects in mice. Phytother Res 1989; 3: 180-3.
76. Claeson P, Rådström P, Sköld O, Nilsson Å, Hoglund S. Bactericidal Effect of the Sesquiterpene T-Cadinol on Staphylococcus aureus. Phytother Res 1992; 6: 94-8.
77. Groppo FC, Bergamaschi CC, Cogo K, Franz-Montan M, Motta RHL, Dias de Andrade E. Use of Phytotherapy in Dentistry. Phytother Res 2008; 22: 993-8.
78. Dolara P, Corte B, Ghelardini C, et al. Local anaesthetic, antibacterial and antifungal properties of sesquiterpenes from myrrh. Planta Med 2000; 66: 356-8.
79. Rahman MM, Garvey M, Piddock LJV, Gibbons S. Antibacterial terpenes from the oleo-resin of Commiphora molmol (Engl.). Phytother Res 2008; 22: 1356-60.
80. Andrews JM. The development of the BSAC standardized method of disc diffusion testing. J Antimicrob Chemoth 2001; 48: 29-42.
81. Manguro LOA, Ugi I, Lemmen P. Further bisabolenes and dammarane triterpenes of Commiphora kua resin. Chem Pharm Bull 2003; 51: 479-82.
82. Homan AL, Fuchs A. Direct bioautography on thin layer chromatograms as a method for detecting fungitoxic substances. J Chromatogr 1970; 51: 327-9.
83. Asres K, Tei A, Moges G, Sporer F, Wink M. Terpenoid Composition of the wound-induced bark exudates of Commiphora tenuis from Ethiopia. Planta Med 1998; 64: 473-5.
84. Andrikopoulos NK, Kaliora AC, Assimopoulou AN, Papapeorgiou VP. Biological activity of some naturally occurring resins, gums and pigments against in vitro LDL oxidation. Phytother Res 2003; 17: 501-7.
85. Thomas S, Stefanos D, Chmielewska E, Chmielewska W. Distribution, development and structure of resin ducts in Pistachia lentiscus var. chia Duhamel. Flora 2000; 195: 83-94.
86. Kühn CG. (Ed.), 1826. Claudii Galeni opera omnia, vol. 12. Leipzig, Knobloch.
87. Sharifi MS, Hazell SL. Fractionation of mastic gum in relation to antimicrobial activity. Pharmaceuticals 2009; 2: 2-10.
88. Paraschos S, Magiatis P, Mitakou S, et al. In vitro and in vivo activities of Chios mastic gum extracts and constituents against Helicobacter pylori. Antimicrob Ag Chemoth 2007; 51: 551-9.
89. Barton DH, Seaone E. The Constitution and Stereochemistry of Masticadienonic Acid. J Chem Soc 1956; 801: 4150-8.
90. Van den Berg J, Horst K, Jaap J, Sudmeijer J, Sudmeijer B. Cis-1,4-poly-_-myrcene; The Structure of the polymeric fraction of mastic resin (Pistachia lentiscus L.) elucidated. Tetrahedron Lett 1998; 39: 2645-8.
91. Sterer N. Antimicrobial effect of mastic gum methanolic extract against Porphyromonas gingivalis, J Med Food 2006; 9: 290-2.
92. Sterer N, Nuas S, Mizrahi B, Goldenberg C, Weiss EI, Domb A, Davidi MP. Oral malodor reduction by a palatal mucoadhesive tablet containing herbal formulation. J Dent 2008; 36: 535-9.
93. Aksoy A, Duran N, Koksal F. In vitro and in vivo antimicrobial effects of mastic chewing gum against Streptococcus mutans and mutans streptococci. Arch Oral Biol 2006; 51: 476-81.
94. Protopapa EE, Spiliotis V, Kefala V, Triantafyllou A, Tsaknis J. The antibacterial and the antifungal action of the Chios mastic essential oil. Rev Clin Pharmacol Pharmacokin, Int Ed 2001; 15: 199-201.
95. Takahashi K, Fukazawa M, Motohia H, Ochiai K, Nishikawa H, Miyata T. A pilot study on antiplaque effects ofmastic chewing gum in the oral cavity. J Periodontol 2003; 74: 501-5.
96. Aksoy A, Duranb N, Torogluc S, Koksald F. Short-term effect of mastic gum on salivary concentrations of cariogenic bacteria in orthodontic patients. Angle Orthod 2007; 77: 124-8.
97. Al-Said MS, Ageel AM, Parmer NS, Tariq M. Evaluation of mastic, a crude drug obtained from Pistachio lentiscus for Gastric and Duodenal Anti-Ulcer Activity. J Ethnopharmacol 1986; 15: 271-8.
98. Al-Habbal MJ, Zakaria Al-Habbal Z, Huwez FU. A double-blind controlled clinical trial of mastic and placebo in the treatment of duodenal ulcer. Clin Exp Pharmacol Physiol 1984; 11:541-4.
99. Huwez FU, Thorwell D, Cockayne A, Ala'Aldeen DA. Mastic gum kills Helicobacter pylori. New Engl J Med 1998; 346: 1946.
100. Marone P, Bono L, Leone E, Bona S, Carretto E, Perversi L. Bactericidal activity of Pistacia lentiscus mastic gum against Helicobacter pylori. J Chemotherapy 2001; 13: 611-4.
101. Loughlin MF, Ala'Aldeen DA, Jenks PJ. Monotherapy with mastic does not eradicate Helicobacter pylori infection from mice. J. Antimicrob. Chemother 2003; 51: 367-71.
102. Bebb J, Bailey-Flitter N, Ala'Aldeen D, Atherton J. Mastic gum has no effect on Helicobacter pylori load in vivo. J Antimicrob Chemoth 2003; 52: 522-3.
103. Dabos KJ, Sfika E, Vlatta LJ, Giannikopoulos G. The effect of mastic gum on Helicobacter pylori: A randomized pilot study. Phytomed 2010; 17: 296-9.
104. Kottakis F, Befani C, Asiminas A, Kontou M, Koliakos G, Choli-Papadopoulou T. The C-terminal region of HPNAP activates neutrophils and promotes their adhesion to endothelial cells. Helicobacter 2009; 14: 177-9.
105. Kottakis F, Lamari F, Matragkou Ch, Zachariadis G, Karamanos N, Choli-Papadopoulou T. Arabino-galactan proteins from Pistacia lentiscus var. chia: isolation, characterization and biological function. Amino Acids 2008; 34: 413-20.
106. Dabos KJ, Sfika E, Vlatta LJ, Frantzi D, Amygdalos GI, Giannikopoulos G. Is Chios mastic gum effective in the treatment of functional dyspepsia? A prospective randomised double-blind placebo controlled trial. J Ethnopharmacol 2010; 127: 205-9.
107. Duke J. Medicinal plants of the bible, Trado-Medic Books, New York; 1983.
108. Tassou CC, Nychas GJE. Antimicrobial activity of the essential oil of mastic gum (P. lentiscus var. Chia) on Gram positive and Gram negative bacteria in broth and in model food system. Int Biodeter Biodegr 1995; 36: 411-20.
109. Magiatis P, Melliou E, Skaltsounis A L, Chinou IB, Mitaku S. Chemical composition and antimicrobial activity of the essential oils of Pistacia lentiscus var. chia. Planta Med 1999; 65: 749-52.
110. Koutsoudaki C, Krsek M, Rodger A. Chemical composition and antibacterial Activity of the essential oil and the gum of Pistacia lentiscus Var. chia. J Agric Food Chem 2005; 53: 7681-5.
111. Daifas DP, Smith JP, Blanchfield B, Sanders G, Austin JW, Koukoutisis J. Effects of mastic resin and its essential oil on the growth of proteolytic Clostridium botulinum. Int J Food Microbiol 2004; 94: 313-22.
112. Ali-Shtayeh MS, Abu Ghdeib SI. Antifungal activity of plant extracts against dermatophytes. Mycoses 1999; 42: 665-72.
113. Sakagami H, Kishino K, Kobayashi M, et al. Selective antibacterial and apoptosis-modulating activities of mastic. In Vivo 2009; 23; 215-24.
114. Thuille N, Fille M, Nagl M. Bactericidal activity of herbal extracts. Int J Hyg Envir Heal 2003; 206: 217-21.
115. Gupta D, Bleakley B, Gupta RK. Dragon's blood: Botany, chemistry and therapeutic uses. J Ethnopharmacol 2008; 115: 361-80.
116. Cai XT, Xu ZF. Studies on the plant origin of Chinese Dragon's blood. Act Bot Yunn 1979; 1: 1-9.
117. Bensky D, Gamble A. Chinese Herbal Medicine: Materia Medica, Eastland Pr. China 1993.
118. Carlson TJS, King SR. Sangre de Drago (Croton lechleri Muell.-Arg.)-A phytomedicine for the treatment of diarrhoea. Health Notes Rev Compl. Integr. Med 2000; 7: 315-20.
119. Jones K. Review of Sangre de Drago (Croton lechleri)-A South American tree sap in the treatment of diarrhoea, inflammation, insect bites, viral infections, and wounds: traditional uses to clinical research. J Altern Complement Med 2003; 9: 877-96.
120. Gonzales GF, Valerio Jr LG. Medicinal plants from Peru: a review of plants as potential agents against cancer. Anticancer Agents Med Chem 2006; 6: 429-44.
121. Chen ZP, Cai Y, Phillipson JD. Studies on the anti-tumor, antibacterial, and wound-healing properties of Dragon's blood. Planta Med 1994; 60: 541-5.
122. Pieters L, De Bruyne T, Van Poel B, Vingerhoets Totté J, Vanden Berghe D, Vlietinck A. In vivo wound healing activity of Dragon's blood (Croton spp.), a traditional South American drug, and its constituents. Phytomed 1995; 2: 17-22.
123. Miller MJS, MacNaughton WK, Zhang XJ, et al. Treatment of gastric ulcers and diarrhoea with the Amazonian herbal medicine sangre de grado. Am J Physiol-Gastr L 2000; 279: G192-200.
124. Wang XH, Zhang C, Yang LL, Gomes-Laranjo J. Production of dragon's blood in Dracaena cochinchinensis plants by inoculation of Fusarium proliferatum. Plant Sci 2010; In press DOI: 10.1016/j.plantsci.2010.09.007
125. Wang J, Ruan D, Cheng Z, Zhou L. Phytoalexins in Dracaena cochinchinensis resin. Chinese J Appl Ecol 1999; 10: 255-6.
126. Jiang DF, Ma P, Yang J, et al. Formation of blood resin in abiotic Dracaena cochinchinensis inoculated with Fusarium 9568D. Chin. J. Appl. Eco 2003; 14: 477-8.
127. Wang JL, Li XC, Jiang DF, Yang CR. Chemical constituents of Dragon's blood resin from Dracaena cochinchinensis in Yunnan and their antifungal activity. Acta Bot. Yunn 1995; 17: 336-40.
128. Gupta D, Bleakley B, Gupta RK. Bioassay guided isolation of antibacterial homoisoflavan from Dragon's blood resin (Dammulakhwain). Nat Prod Rad 2009; 8: 494-7.
129. Kumar VP, Chauhan NS, Padh H, Rajani M. Search for antibacterial and antifungal agents from selected Indian medicinal plants. J Ethnopharmacol 2006; 107: 182-8.
130. Mothana RAA, Lindequist U. Antimicrobial activity of some medicinal plants of the island Soqotra. J Ethnopharmacol 2005; 96: 177-81.
131. Mitscher LA, Leu RP, Bathala MS, Wu WN, Beal JL, White R. Antimicrobial agents from higher plants. 1. Introduction, rationale and methodology. Lloydia 1972; 35: 157-66.
132. Badib AS. Medicinal Plants of the Yemen. Maktabah Alirsad, Sanaa 1991; 15.
133. Piozzi F, Passannanti S, Paternostro MP, Nasini G. Diterpenoid resin acids of Daemonorops draco. Phytochem 1974; 13: 2231-3.
134. Rao GSR, Gehart MA, Lee III RT, Mitscher LA, Drake S. Antimicrobial agents from higher plants: Dragon's blood resin. J Nat Prod 1982; 45: 646-8.
135. Phillipson D. Phytochemistry and medicinal plants. Phytochem 2001; 56: 237-43.
136. Kostova I, Iossifova T, Rostan J, Vogler B, Kraus W, Navas H. Chemical and biological studies on Croton panamensis latex (Dragon's blood). Pharmac Pharmacol Lett 1999; 9: 34-6.
137. Peres MTLP, Delle Monache F, Cruz AB, Pizzolatti MG, Yunes RA. Chemical composition and antimicrobial activity of Croton urucurana Baillon (Euphorbiaceae). J Ethnopharmacol 1997; 56: 223-6.
138. Silva Junior IF, Filho VC, Zacchino SA, da S. Lima LC, de O. Martins DT. Antimicrobial screening of some medicinal plants from Mato Grosso Cerrado. Brazil J Pharmacogn 2009; 19: 242-8.
139. Oliveira IS, Lima JCS, Silva RM, Martins DTO. In vitro screening of antibacterial activity of the latex and extracts from Croton urucurana Baillon. Brazil J Pharmacogn 2008; 18: 587-93.
140. Gurgel LA, Sidrim JJC, Martins DT, Cechinel Filho V, Rao VS. In vitro antifungal activity of dragon's blood from Croton urucurana against dermatophytes. J Ethnopharmacol 2005; 97: 409-12.
141. Okubo S, Toda M, Hara Y, Shimamura T. Antifungal and fungicidal activities of tea extract and catechins against Trichophyton. JPN J Bacteriol. 1991; 46; 509-14.
142. Chen ZP, Cai Y, Phillipson JD. Studies on the anti-tumor, antibacterial, and wound-healing properties of Dragon's blood. Planta Med 1994; 60: 541-5.
143. Mc Chesney JD, Clark AM. Antimicrobial diterpenes of Croton soderianus 1. Hardwick and 3,4-secotrachylobanoic acids. J Nat Prod 1991; 54: 1625-33.
144. Lewis R.J., Sax's Dangerous Properties of Industrial Materials, 10th edn., J. Wiley, 2000, PGR000; 1992, TKY250.
145. Simone-Finstrom M, Spivak M. Propolis and bee health: the natural history and significance of resin use by honey bees. Apidologie 2010; 41: 295-311.
146. Simone M, Evans JD, Spivak M. Resin collection and social immunity in honey bees. Evolution 2009; 63: 3016-22.
147. Orozco AL, Acevedo JGA, Martinez MMC, et al. Antibacterial comparative study between extracts of mexican propolis and of three plants which use Apis mellifera for its production J Anim Vet Adv 2010; 9: 1250-4.
148. Bankova V. Recent trends and important developments in propolis research. eCAM 2005; 2: 29-32.
149. Higashi KO, de Castro SL. Propolis extracts are effective against Trypanosoma cruzi and have an impact on its interaction with host cells. J Ethnopharmacol 1994; 43: 149-55.
150. Burdock GA. Review of the biological properties and toxicity of bee propolis. Food Chem Toxicol 1998; 36: 347-63.
151. Cushnie TPT, Lamb AJ. Detection of galangin-induced cytoplasmic membrane damage in Staphylococcus aureus by measuring potassium loss. J Ethnopharmacol 2005; 101: 243-8.
152. Takaisi NB, Scjoncjer H. Electron microscopy and microcalorimetric investigations of the possible mechanism of the antibacterial action of a defined propole provenance. Planta Med 1994; 60: 222-7.
153. Ghisalberti EL. Propolis. A review. Bee World 1979; 60: 59-84.
154. Seidel V, Peyfoon E, Watson DG, Fearnley J. Comparative study of the antibacterial activity of propolis from different geographical and climatic zones. Phytother Res 2008; 22: 1256-63.
155. Grange JM, Davey RW. Antibacterial properties of propolis (bee glue). J Royal Soc Med 1990; 83: 159-60.
156. Marcucci MC. Propolis: chemical composition, biological properties and therapeutic activity. Apidologie 1995; 26: 83-99.
157. Kujumgiev A, Tsvetkova I, Serkedjieva Y, Bankova V, Christov R, Popov S. Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. J Ethnopharmacol 1999; 64: 235-40.
158. Silici S, Unlu M, Vardar-Unlu G. Antibacterial activity and phytochemical evidence for the plant origin of Turkish propolis from different regions. World J Microb Biot 2007; 23: 1797-803.
159. Yildirim Z, Hacievliyagil S, Kutlu NO, et al. Effect of water extract of Turkish propolis on tuberculosis infection in guinea-pigs. Pharmacol Res 2004; 49: 287-92.
160. Raghukumar R, Vali L, Watson D, Fearnley J, Seidel V. Antimethicillin-resistant Staphylococcus aureus (MRSA) activity of 'Pacific Propolis' and isolated prenylflavanones. Phytother Res 2010; 24: 1181-87.
161. Pepeljnjak S, Kosalec I. Galangin expresses bactericidal activity against multiple-resistant bacteria: MRSA, Enterococcus spp. and Pseudomonas aeruginosa. FEMS Microbiol Lett 2004; 240: 111-6.
162. Popova MP, Chinou IB, Marekov IN, Bankova VS. Terpenes with antimicrobial activity from Cretan propolis. Phytochem 2009; 70: 1262-71.
163. Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev 1999; 12: 564-82.
164. Kalogeropoulos N, Konteles SJ, Troullidou E, Mourtzinos I, Karathanos VT. Chemical composition, antioxidant activity and antimicrobial properties of propolis extracts from Greece and Cyprus. Food Chem 2009; 116: 452-61.
165. Banskota AH, Tezuka Y, Adnyana IK, et al. Hepatoprotective and anti-Helicobacter pylori activities of constituents from Brazilian propolis. Phytomed 2001; 8: 16-23.
166. Prytzyk E, Dantas AP, Salomão K, et al. Flavonoids and trypanocidal activity of Bulgarian propolis. J Ethnopharmacol 2003; 88: 189-93.
167. Doetsch RN. Manual Methods for General Bacteriology. Washington, DC: American Society of Microbiology Publishing House 1981; 233.
168. Starzyk J, Scheller S, Szaflarski J, Moskwa M, Stojko A. Biological properties and clinical application of Propolis. II. Studies on the antiprotozoan activity of ethanol extract of propolis. Arznei-Forschung 1977; 27: 1198-9.
169. Miyares C, Hollands I, Castaneda C, et al. Ensayo terapeutico con un preparado a base de propoleo 'propolisina' en la giardiasis del humano. Acta Gastro-Ent Latinoam 1988; 18: 195-201.
170. Salomao K, Pereira PRS, Campos LC, et al. Brazilian propolis: correlation between chemical composition and antimicrobial activity. eCAM 2008; 5: 317-24.
171. Marcucci MC, Ferreres F, García-Viguera C, et al. Phenolic compounds from Brazilian propolis with pharmacological activities. J Ethnopharmacol 2001; 74: 105-12.
172. Fernandes Júnior A, Balestrin EC, Betoni JEC, de Oliveira Orsi R, da Cunha MLRS, Montelli AC. Propolis: anti-Staphylococcus aureus activity and synergism with antimicrobial drugs. Mem Inst Oswaldo Cruz 2005; 100: 563-6.
173. Ota C, Unterkircher C, Fantinato V, Shimizu MT. Antifungal activity of propolis on different species of Candida. Mycoses 2001; 44: 375-8.
174. Silici S, Koç NA, Ayangil D, Çankaya S. Antifungal activities of propolis collected by different races of honeybees against yeasts isolated from patients with superficial mycoses. J Pharmacol Sci 2005; 99: 39-44.